Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST (POETIG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03171389
Recruitment Status : Unknown
Verified May 2017 by Sebastian Bauer, Universität Duisburg-Essen.
Recruitment status was:  Recruiting
First Posted : May 31, 2017
Last Update Posted : May 31, 2017
Sponsor:
Collaborators:
Hannover Medical School
Helios Klinikum Berlin-Buch
University Hospital Tuebingen
Universitätsmedizin Mannheim
University Hospital, Aachen
Helios Klinikum Bad Saarow
WiSP GmbH
Information provided by (Responsible Party):
Sebastian Bauer, Universität Duisburg-Essen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 22, 2018
Estimated Study Completion Date : September 22, 2020